|
Jul 29
|
Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease
|
|
Jul 28
|
China Medical System （867.HK, 8A8.SG）NDA for the Improved New Drug ZUNVEYL for Alzheimer’s Disease Accepted in China
|
|
Jul 21
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
|
|
Jul 15
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today
|
|
Jun 25
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange
|
|
Feb 14
|
China Medical System （867.HK） is Included in the S&P Global Sustainability Yearbook 2025
|
|
Feb 11
|
3 Prominent Dividend Stocks To Consider For Your Portfolio
|
|
Jun 18
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
|
|
Jan 2
|
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
|
|
Dec 13
|
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
|
|
Dec 4
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
|